This trial is conducted in the United States of America (USA). The aim of this trial is to
assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to
insulin lispro, both in insulin pumps, in standard clinical practice.
- People with Type I or Type II Diabetes
- 18 Years or Older.